ArticlePoultry science2025
Improving health and productivity in laying hens with the phage cocktail SalmoFree®.
Article in Poultry science, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Sustainable AGP alternatives: a systems approach to non-antibiotic growth regulators standardization, synergistic formulation and environmental safety.Frontiers in veterinary science · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Avian salmonellosis, caused by Salmonella enterica sub. enterica serovar Gallinarum, represents a substantial threat to poultry production in Latin America. This study assessed the efficacy of the phage cocktail SalmoFree®, which comprises six lytic bacteriophages, in preventing avian salmonellosis in two commercial laying hen farms in Colombia. A total of 95,491 hens were observed over two production cycles under field conditions. The study involved baseline assessments followed by the preventive administration of SalmoFree® via drinking water at regular intervals. Effectiveness was evaluated through microbiological, histopathological, and serological analyses, alongside monitoring of zootechnical parameters and genomic characterization of bacterial isolates. S. Gallinarum was sporadically isolated during the trial; however, in barns where phages were administered, mortality was controlled without antibiotics, in contrast to baseline barns where antibiotics were necessary. Histopathological findings confirmed tissue lesions consistent with salmonellosis, particularly in baseline groups. Zootechnical evaluations indicated that phage administration was associated with reduced mortality and enhanced egg production, with statistically significant improvements observed in one of the farms. Genomic analysis of S. Gallinarum confirmed all isolates as ST78, possessing multiple virulence genes and mutations associated with ciprofloxacin resistance. Escherichia coli isolates exhibited high genomic diversity and multidrug resistance profiles; these isolates were also evaluated to determine whether phage use against Salmonella affected the resistance profile of other bacteria present in the birds. However, no correlation was found between phage administration and resistance gene abundance or MIC values in Salmonella and E. coli isolates. These findings demonstrate the preventive potential of SalmoFree® against avian salmonellosis under commercial conditions and support its role as a complementary tool for antimicrobial-free disease control in poultry production.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.